SWIFTMERGE ACQUISITION

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	IVCP
ISIN:	KYG638361033

Overview
News
Analyses
Profile
Wall

SWIFTMERGE ACQUISITION overview

SWIFTMERGE ACQUISITION > News Business Wire published a news.

HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment • • Business Wire • Stocks • More SWIFTMERGE ACQUISITION news...

NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special purpose acquisition company, announced today the signing of a non-binding letter of intent (“LOI”) for a business combination with HDL Therapeutics Inc. (“HDL Therapeutics”), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy for reducing coronary atheroma in homozygous familial hypercholesterolemia (HoFH)...

Thank you

Load more content